SKHCF (SKHCF) Stock Price & Analysis
SKHCF (SKHCF) rose 0.00% to USD 13.8 as of July 25, 2026 at 04:57 UTC, according to Nexqual real-time market data.
SKHCF last closed at USD 13.8; the session ranged USD 13.8–13.8 on volume of 130 shares. Market capitalization is $7.31B, with a 52-week range of USD 12–19.34 (PNK). Source: Nexqual, July 25, 2026 at 04:57 UTC.
Key Statistics (as of July 25, 2026 at 04:57 UTC)
| Price | USD 13.8 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 13.8 |
| Open | USD 13.8 |
| Day Range | USD 13.8 – 13.8 |
| 52-Week Range | USD 12 – 19.34 |
| Volume | 130 shares |
| Market Cap | $7.31B |
| Exchange | PNK |
Technical Analysis (SKHCF)
Nexqual's technical model rates SKHCF "BUY" based on 5 bullish and 2 bearish signals across 125 daily candles, as of July 25, 2026 at 04:57 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 84.95 (overbought) |
| vs SMA50 | Above (USD 12.86) |
| MACD | 0.27 (positive) |
Analyst Ratings (SKHCF)
Wall Street analysts rate SKHCF "None", per Nexqual as of July 25, 2026 at 04:57 UTC.
| Consensus Rating | None |
|---|
Earnings (SKHCF)
Source: Nexqual, July 25, 2026 at 04:57 UTC.
Financials & Fundamentals (SKHCF)
| Total Revenue | $10.42B |
|---|---|
| Revenue Growth (YoY) | +16.60% |
| Gross Margin | +32.84% |
| Operating Margin | +8.98% |
| Profit Margin | +5.18% |
| ROE | +6.63% |
| Debt / Equity | 68.22 |
| Current Ratio | 1.01 |
| Total Cash | $557.12M |
| Total Debt | $5.95B |
| Free Cash Flow | $597.78M |
Source: Nexqual, July 25, 2026 at 04:57 UTC.
Financial Health Score (SKHCF)
Nexqual rates SKHCF's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 04:57 UTC.
| Growth | Solid — Revenue +7% YoY (annual) |
|---|---|
| Profitability | Solid — Gross margin 33%, operating 9% |
| Balance Sheet | Solid — $557M cash vs $5.95B debt |
| Cash Flow | Solid — FCF $598M, 6% margin |
| Efficiency | Mixed — ROE 7%, ROA 3.8% |
Ownership (SKHCF)
| Insider Ownership | +7.99% |
|---|---|
| Institutional Ownership | +43.43% |
| Shares Outstanding | 494.24M |
| Float | 458.20M |
Source: Nexqual, July 25, 2026 at 04:57 UTC.
Leadership (SKHCF)
SKHCF is led by James Pacey Newcombe, MD, CEO & Executive Director, per Nexqual as of July 25, 2026 at 04:57 UTC.
| MD, CEO & Executive Director | James Pacey Newcombe |
|---|---|
| Finance Director, CFO & Executive Director | Christopher David Wilks B.Com., F.A.C.I.D., F.A.I.C.D. (age 67) |
| Group Chief Operating Officer | Evangelos Kotsopoulos |
Major Backers & Investors (SKHCF)
Notable institutional backers of SKHCF include Fidelity, John Hancock Investment Trust-Disciplined Value International Fund, TRANSAMERICA FUNDS-Transamerica International Equity, according to Nexqual as of July 25, 2026 at 04:57 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Fidelity | 1.02% |
| John Hancock Investment Trust-Disciplined Value International Fund | 0.92% |
| TRANSAMERICA FUNDS-Transamerica International Equity | 0.34% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 2.3% |
| BlackRock | 1.01% |
| Dimensional Fund Advisors | 0.42% |
Source: Nexqual, July 25, 2026 at 04:57 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SKHHY | Sonic Healthcare Ltd. | USD 14.86 | ▲ 1.92% |
| STMEF | STMicroelectronics N.V. | USD 51.92 | ▼ 17.15% |
| CLPXY | China Longyuan Power Group | USD 7.7 | ▲ 15.27% |
| JPXGY | Japan Exchange Group, Inc. | USD 13.65 | ▲ 0.55% |
| PTAIY | PT Astra International | USD 5.55 | ▼ 3.48% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 04:57 UTC. This page is informational and not investment advice.